http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015512404-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate | 2013-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2015512404-A |
titleOfInvention | Schweinfurtin analog |
abstract | The present invention provides a compound of formula (I), wherein R 1 -R 5 have any of the values defined herein. The compounds are useful for the treatment of cancer and other diseases. The present invention also provides a pharmaceutical composition comprising a compound of formula (I), or a pharmaceutically acceptable salt thereof, in combination with a pharmaceutically acceptable diluent or carrier. In addition, the present invention provides a method for treating cancer comprising administering an effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, to a mammal in need of treatment for cancer. Provide treatment. |
priorityDate | 2012-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.